André Lacroix

Centre Hospitalier de l’Université de Montréal — Canada

Medicine · Health Sciences

72h-index22.5kcitations524works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(189), Adrenal and Paraganglionic Tumors(163), Adrenal Hormones and Disorders(115), Hormonal Regulation and Hypertension(77), Growth Hormone and Insulin-like Growth Factors(35)

Publications523 total

Osilodrostat for Bilateral Adrenal Hypercortisolism in Primary Aldosteronism
New England Journal of Medicine·2025· 2 cited
Adrenal Cortex and Medulla Physiology during Pregnancy, Labor, and Puerperium
Elsevier eBooks·2025
Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4
European Journal of Endocrinology·2025· 4 citedOpen Access
SUN-071 Long-term Safety and Effectiveness of Osilodrostat in Patients with Cushing’s Disease in the LINC Rollover Study
Journal of the Endocrine Society·2025Open Access
Update on Medical Treatment of Cushing’s Syndrome
Drugs·2025· 3 citedOpen Access
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling
European Journal of Endocrinology·2025· 11 citedOpen Access
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
Pituitary·2025· 2 citedOpen Access
Safety and effectiveness of >8 years of osilodrostat treatment in patients with cushing's disease: findings from the LINC rollover open-label, multicentre study
Endocrine Abstracts·2025
Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
Pituitary·2025· 11 citedOpen Access
Cushing syndrome
Nature Reviews Disease Primers·2025· 31 citedOpen Access
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
The Lancet Diabetes & Endocrinology·2025· 41 citedOpen Access
Cushing's syndrome screening and differential diagnosis
Elsevier eBooks·2025
Primary bilateral macronodular adrenal hyperplasia
Elsevier eBooks·2025
Chapitre 1 / L’institutionnalisation de l’éthique : entre la réalité et la réflexion, il y a l’imaginaire
Presses de l'Université du Québec eBooks·2024
Introduction / L’institutionnalisation de l’éthique et ses défis : quelques remarques préliminaires
Presses de l'Université du Québec eBooks·2024
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol
Journal of the Endocrine Society·2024· 13 citedOpen Access
7236 Long Term Extension of Osilodrostat Therapy in Canadian Patients with Cushing’s Disease Benefiting from the LINC 3 and LINC 4 Studies
Journal of the Endocrine Society·2024Open Access
7230 Complete Nine Years Disease Free Survival In A Patient With Metastatic Adrenocortical Carcinoma Following Systemic Chemotherapy Including Streptozotocin And Mitotane
Journal of the Endocrine Society·2024Open Access
6907 Continued Improvements in Hypertension and Diabetes During Long-Term Osilodrostat Therapy in Patients with Cushing’s Disease: A Pooled Analysis from the Phase III LINC 3 and LINC 4 Studies
Journal of the Endocrine Society·2024· 1 citedOpen Access
8528 An Unusual Case Of Adrenal Hemorrhage As An Initial Manifestation Of Castleman Disease In A 29 yo Male With Unsuspected Late-Onset Congenital Adrenal Hyperplasia
Journal of the Endocrine Society·2024Open Access
page 1 of 27Next →

Frequent Co-authors

Pavel Hamet(9), Isabelle Bourdeau(8), John Newell‐Price(7), Constantine A. Stratakis(6), Johanne Tremblay(6), Lynnette K. Nieman(5), Rosario Pivonello(5), Michel Gagner(4), E. Bolté(4), James W. Findling(4), Beverly M. K. Biller(4), Stephan Petersenn(4), Urs Granacher(4), Richard A. Feelders(3), Xavier Bertagna(3), Marco Boscaro(3), Antoine Tabarin(3), Alfons Pomp(3), Richard J. Auchus(3), Maria Fleseriu(3)